p-Toluenesulfonic acid → HCID 46206559, compound

HRID 389736Notes

Reaction equation

HRID 389736 reaction equation
[C:1]([C:4]1[N:5]=[C:6]([C:28]2[CH:36]=[C:35]3[C:31]([CH:32]=[CH:33][NH:34]3)=[CH:30][CH:29]=2)[O:7][C:8]=1[C:9]1[CH:14]=[CH:13][C:12]([N:15]2[CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17][CH2:16]2)=[CH:11][CH:10]=1)(=[O:3])[NH2:2].CC1C=CC(S(O)(=O)=O)=CC=1>CO>[NH:34]1[C:35]2[C:31](=[CH:30][CH:29]=[C:28]([C:6]3[O:7][C:8]([C:9]4[CH:10]=[CH:11][C:12]([N:15]5[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]5)=[CH:13][CH:14]=4)=[C:4]([C:1]([NH2:2])=[O:3])[N:5]=3)[CH:36]=2)[CH:32]=[CH:33]1

Participants

4

Procedure

A solution of tert-butyl 4-(4-(4-carbamoyl-2-(1H-indol-6-yl)oxazol-5-yl)phenyl)piperazine-1-carboxylate (0.018 g, 0.04 mmol) in MeOH was loaded onto a MP-TsOH cartridge (500 mg). The cartridge was washed with MeOH and allowed to stand for 2 hours. The cartridge was then washed with 2M ammonia in MeOH and the solvent removed in vacuo. The residue was purified by preparative HPLC to afford 2-(1H-indol-6-yl)-5-(4-(piperazin-1-yl)phenyl)oxazole-4-carboxamide (0.006 g, 0.02 mmol, 50%). 1H NMR (DMSO) δ 2.85 (4H, t), 3.20 (4H, t), 6.55 (1H, m), 7.04 (2H, d), 7.55 (1H, br. s), 7.56 (1H, m), 7.68 (1H, br. s), 7.71 (1H, d), 7.77 (1H, dd), 8.15 (1H, s), 8.26 (2H, d), 11.48 (1H, br. s). LCMS (2) Rt: 2.32 min; m/z (ES+) 388.

Workup

  1. washThe cartridge was washed with MeOH
  2. washThe cartridge was then washed with 2M ammonia in MeOH
  3. customthe solvent removed in vacuo
  4. customThe residue was purified by preparative HPLC

Sources & evidence

ORD record
ord-862091a246774be1a18e8cd190e55aa2
Source dataset
uspto-grants-2013_02
Patent number
US08378095B2

Reaction notes

Loading…